Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe manufacturing cost of Wegovy is not publicly disclosed by Novo Nordisk, and it has no direct bearing on what you pay at a UK pharmacy. What drives private Wegovy pricing is the list price Novo Nordisk sets for the UK market, the costs a pharmacy builds in for clinical assessment, dispensing and delivery, and the margin each provider chooses to work at. Wegovy is a prescription-only medicine in the UK, which means it can only be supplied following a clinical assessment by a prescriber — the price you see from any legitimate source should reflect that, not just the cost of the pen itself. Understanding how that price is built up is the most useful thing this page can tell you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Novo Nordisk sets a UK list price for each Wegovy pen. That figure is not manufacturing cost; it reflects research and development investment, regulatory approval costs, supply-chain logistics and the company's commercial decisions for the UK market. Pharmacies buy stock through the licensed UK supply chain at or near that list price, which sets a floor below which legitimate supply simply cannot go.
Wegovy comes in five dose steps (0.25 mg through to 2.4 mg) and more recently a 7.2 mg pen was approved by the MHRA in April 2026. Because pens differ in the amount of active medicine they contain, the list price varies by dose. You can read through what Wegovy typically costs month to month as dose increases during titration, but the short version is that monthly spend rises as you move up the schedule.
One practical consequence: a provider offering Wegovy at a price that looks dramatically lower than the market is either subsidising losses (unsustainable) or the supply is not what it claims to be. The MHRA has warned publicly about counterfeit weight-loss pens sold online, and reporting suspect sellers via the MHRA Yellow Card scheme is the right move if something doesn't look right.
A legitimate private provider adds several layers on top of the list price. Clinical assessment is the first: under UK law, Wegovy cannot be dispensed without a valid prescription, and producing that prescription requires a qualified prescriber to assess you. Many providers charge this as a separate consultation fee. A dispensing fee, packaging and delivery costs follow. The total cost of Wegovy from a private pharmacy depends on how many of these elements are bundled or broken out.
Some headline prices look low because they show the pen cost alone. The consultation fee, the prescription charge and delivery are then added at the point of purchase. For a treatment you take every week, those extras accumulate quickly. It is worth checking what a quoted price actually includes before assuming it is comparable to another provider's all-in figure.
According to NICE's recommendation for semaglutide (TA875), Wegovy is intended to be used alongside dietary and activity support, so the clinical oversight built into a good service is not optional padding; it is part of how the treatment is meant to work.
Because Wegovy titration runs over several months, your spend is not fixed from the outset. The 0.25 mg starting pen costs less than the 2.4 mg maintenance pen, which makes the first month the cheapest, not necessarily the most representative. If you are comparing prices between providers, check what they charge at the dose you expect to reach, not just the starter.
Dose-specific pricing is covered in detail for the 1.7 mg dose and the 2.4 mg maintenance dose separately. For semaglutide in general, including how Wegovy compares to other branded options, the semaglutide cost overview sets out the broader picture.
If you are already on Wegovy and looking at what a lower-dose step costs, the guidance on lower-priced Wegovy doses is the clearest starting point.
Here is the honest bit. We know many people searching for Wegovy cost information are frustrated: frustrated with NHS waiting times, with confusing pricing across providers, with not knowing whether a cheaper option is safe. That frustration is completely understandable, and it is exactly why transparent pricing matters.
nume is not the cheapest option. That is a deliberate choice. One price covers the consultation, the prescription, the medicine and free next-working-day tracked delivery, no separate fees, no subscription, no unpleasant surprises at checkout. See what that all-in price covers on the treatment page. Every repeat order goes back to a prescriber for clinical re-review; dose changes are not automated. Our clinical team reviews consultations personally, the same day, during working hours.
For a prescription medicine, price is the wrong test. The questions that actually protect you: is this pharmacy registered with the GPhC? Is a real prescriber assessing me? Is the supply chain licensed? You can verify any UK pharmacy on the GPhC register, our registration number is 9012878. Check it. Then check whoever else you are considering. A small saving on a counterfeit or clinically unsupervised pen is not a saving at all. Our weight-loss treatment overview covers what supervised care actually looks like in practice.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.